Phenotyping in COPD: Tailoring treatment to each patient

Professor Arschang Valipour is this week’s expert guest on the Medical Insider COPD podcast. Join him and Dr Richard Russell as they discuss the role of phenotyping in patients with COPD and how it could influence management decisions. ^1,2 A new publication on the use of low-dose morphine for chronic breathlessness will be discussed by Dr Russell,³ alongside the effects of winter weather on respiratory disease, which has been a hot topic on social media this week. Stay tuned for more exciting topics on the Medical Insider COPD podcast!

¹ Bakeer M, et al. Ann Transl Med 2020;8:1472;
² Koblizek V, et al. Eur Respir J 2017;49:1601556;
³ Currow D, et al. Respir Res 2020;75:50–56.

Disclosures
Professor Arschang Valipour
Professor Valipour reports speaker and/or consultancy fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Menarini, Novartis and Pulmonx.

Bios:

Professor Arschang Valipour
Professor Arschang Valipour is Head of the Department of Respiratory and Critical Care Medicine at Klinik Floridsdorf and Research Director of the Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Vienna, Austria. Dr Valipour was appointed Associate Professor in Pulmonology at that university in 2010. Dr Valipour serves on multiple advisory and data safety monitoring boards and coordinates research as the Principal Investigator of clinical trials in the field of COPD, COVID-19 and Lung Cancer. He is Fellow of the European Respiratory Society (FERS), member of the European Respiratory Society (ERS) College of Experts, and previously served as a Secretary to the Sleep and Breathing Working Group of the ERS.

This series of podcasts are intended for healthcare professionals only.

The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.